Recent Publications

The NCIC have authored and co-authored a suite of clinical publications on the treatment and management of a range of infections in the Immunocompromised Host; available below for your reference.

Feature Papers 2024

Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions

Antibacterial prophylaxis for neutropenic and high-risk hematology patients-Do the benefits outweigh the risk?

Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey data

High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post-Autologous Stem Cell Transplant Period.

 

Full 2024 NCIC Publication List

  1. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
    Kotton, C.N., Kamar, N., Wojciechowski, D., Eder, M., Hopfer, H., Randhawa, P., Sester, M., Comoli, P., Silva, H.T., Knoll, G., Brennan, D.C., Trofe-Clark, J., Pape, L., Axelrod, D., Kiberd, B., Wong, G., Hirsch, H.H., Caillard, S., Fernandez-Ruiz, M., Oberbauer, R., Pierrotti, L., Drachenberg, C., Heher, Y., Huang, G., Mengel, M., Buenrostro, L.M., Nankivell, B., Bertels, L., Vathsala, A., Halary, F., Heim, A., Kumar, D., Leuzinger, K., Rinaldo, C.H., Schaenman, J., Slavin, M., Tedesco-Silva, H., Schaub, S., Benotmane, I., Theodoropoulos, N., Helantera, I., Witzke, O., Chadban, S., Bagchi, S., Elfadawy, N., Dharnidharka, V.R., Hattori, M., Venkataramanan, R., Tönshoff, B., Laskin, B., Abramowicz, D., Cantarovich, M., Crespo, M., Agarwal, S.K., Mueller, N., Tian, Y.-C.
    Transplantation
    DOI: 10.1097/TP.0000000000004976

  2. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
    Teh, B.W., Mikulska, M., Averbuch, D., de la Camara, R., Hirsch, H.H., Akova, M., Ostrosky-Zeichner, L., Baddley, J.W., Tan, B.H., Mularoni, A., Subramanian, A.K., La Hoz, R.M., Marinelli, T., Boan, P., Aguado, J.M., Grossi, P.A., Maertens, J., Mueller, N.J., Slavin, M.A.
    The Lancet Infectious Diseases
    DOI: 10.1016/S1473-3099(23)00377-8

  3. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020
    Hosseini-Moghaddam, S.M., Kothari, S., Humar, A., Albasata, H., Yetmar, Z.A., Razonable, R.R., Neofytos, D., D'Asaro, M., Boggian, K., Hirzel, C., Khanna, N., Manuel, O., Mueller, N.J., Imlay, H., Kabbani, D., Tyagi, V., Smibert, O.C., Nasra, M., Fontana, L., Obeid, K.M., Apostolopoulou, A., Zhang, S.X., Permpalung, N., Alhatimi, H., Silverman, M.S., Guo, H., Rogers, B.A., MacKenzie, E., Pisano, J., Gioia, F., Rapi, L., Prasad, G.V.R., Banegas, M., Alonso, C.D., Doss, K., Rakita, R.M., Fishman, J.A.
    American Journal of Transplantation
    DOI: 10.1016/j.ajt.2023.11.003

  4. Scedosporiosis and lomentosporiosis: Modern perspectives on these difficult-to-treat rare mold infections
    Neoh, C.F., Chen, S.C.-A., Lanternier, F., Tio, S.Y., Halliday, C.L., Kidd, S.E., Kong, D.C.M., Meyer, W., Hoenigl, M., Slavin, M.A.
    Clinical Microbiology Reviews
    DOI: 10.1128/cmr.00004-23

  5. Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?
    Storek, J., Lindsay, J.
    Bone Marrow Transplantation
    DOI: 10.1038/s41409-023-02155-5

  6. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: Guidelines from the 9th European Conference on Infections in Leukaemia, 2022
    Aerts, R., Mehra, V., Groll, A.H., Martino, R., Lagrou, K., Robin, C., Perruccio, K., Blijlevens, N., Nucci, M., Slavin, M., Bretagne, S., Cordonnier, C.
    The Lancet Infectious Diseases
    DOI: 10.1016/S1473-3099(23)00495-4

  7. Infections in patients with lymphoma treated with bispecific antibodies: A systematic review and meta-analysis
    Reynolds, G.K., Maclean, M., Cliff, E.R.S., Teh, B.W., Thursky, K.A., Slavin, M.A., Anderson, M.A., Hawkes, E.A.
    Blood Advances
    DOI: 10.1182/bloodadvances.2024012916

  8. Performance of ICD-10-AM codes for quality improvement monitoring of hospital-acquired pneumonia in a haematology-oncology casemix in Victoria, Australia
    Valentine, J.C., Gillespie, E., Verspoor, K.M., Hall, L., Worth, L.J.
    Health Information Management Journal
    DOI: 10.1177/18333583221131753

  9. Cytomegalovirus drives Vδ1+ γδ T cell expansion and clonality in common variable immunodeficiency
    Chan, S., Morgan, B., Yong, M.K., Margetts, M., Farchione, A.J., Lucas, E.C., Godsell, J., Giang, N.A., Slade, C.A., von Borstel, A., Bryant, V.L., Howson, L.J.
    Nature Communications
    DOI: 10.1038/s41467-024-48527-3

  10. Antimicrobial use and appropriateness in neutropenic fever: A study of the Hospital National Antimicrobial Prescribing Survey data
    Singh, N., Douglas, A.P., Slavin, M.A., Haeusler, G.M., Thursky, K.A.
    Journal of Antimicrobial Chemotherapy
    DOI: 10.1093/jac/dkae015

  11. Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): A pilot safety and feasibility randomised controlled trial
    Rose, M.T., Holmes, N.E., Eastwood, G.M., Vogrin, S., James, F., De Luca, J.F., Bellomo, R., Warrillow, S.J., Phung, M., Barnes, S.L., Murfin, B., Rogers, B., Lambros, B., Collis, B., Peel, T.N., Slavin, M.A., Trubiano, J.A.
    Intensive Care Medicine
    DOI: 10.1007/s00134-024-07448-x

  12. Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000–2022: a binational cohort study
    MacPhail, A., Dendle, C., Slavin, M., Weinkove, R., Bailey, M., Pilcher, D., McQuilten, Z.
    Critical Care
    10.1186/s13054-024-04932-0

  13. Aligning organisational priorities and implementation science for cancer research
    Best, S., Thursky, K., Buzza, M., Klaic, M., Peters, S., Guccione, L., Trainer, A., Francis, J.
    BMC Health Services Research
    10.1186/s12913-024-10801-x

  14. Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study
    Neoh, C.F., Chen, S.C.A., Kong, D.C.M., Hamilton, K., Nguyen, Q.A., Spelman, T., Tew, M., Harvey, E.L., Ho, S.A., Saunders, N.R., Tennakoon, S., Crowe, A., Marriott, D., Trubiano, J.A., Slavin, M.A.
    Journal of Antimicrobial Chemotherapy
    10.1093/jac/dkad345

  15. Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update
    Patel, P., Robinson, P.D., Fisher, B.T., Phillips, R., Morgan, J.E., Lehrnbecher, T., Kuczynski, S., Koenig, C., Haeusler, G.M., Esbenshade, A., Elgarten, C., Duong, N., Diorio, C., Castagnola, E., Beauchemin, M.P., Ammann, R.A., Dupuis, L.L., Sung, L.
    eClinicalMedicine
    10.1016/j.eclinm.2024.102604

  16. Outcomes of Antiviral Retreatment for Immunocompromised Hosts With Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Positivity: A Multicenter Australian Retrospective Case Series
    Bond, K.A., Dendle, C., Guy, S., Slavin, M.A., Smibert, O., Ibrahim, N., Kinsella, P.M., Morrissey, C.O., Moso, M.A., Sasadeusz, J.J.
    Open Forum Infectious Diseases
    10.1093/ofid/ofae449

  17. Editorial introductions
    Slavin, M., Yong, M.K., Bassetti, M.
    Current Opinion in Infectious Diseases
    10.1097/QCO.0000000000001071

  18. Pulmonary complications post allogeneic haematopoietic stem cell transplant in children
    Walker, H., Abbotsford, J., Haeusler, G.M., Yeoh, D., Ramachandran, S., Ng, M., Holzmann, J., Shanthikumar, S., Weerdenburg, H., Hanna, D., Neeland, M.R., Cole, T.
    Clinical and Translational Immunology
    10.1002/cti2.70003

  19. Chimeric antigen receptor-T-cell therapies going viral: Latent and incidental viral infections
    Kampouri, E., Reynolds, G., Teh, B.W., Hill, J.A.
    Current Opinion in Infectious Diseases
    10.1097/QCO.0000000000001066

  20. Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024
    Campbell, B.A., Prince, H.M., Thursky, K., Dabaja, B., Hoppe, R., Specht, L., Morris, S., Porceddu, S.V.
    Seminars in Radiation Oncology
    10.1016/j.semradonc.2024.08.005

  21. A single-center experience of COVID-19 infection in patients with primary immunodeficiency
    Zhou, J.J., Jin, C., Leang, Z.X., Chatelier, J., Godsell, J., Tsang, S., Douglass, J.A., Yong, M.K., Slavin, M., Bryant, V.L., Slade, C.A., Chan, S.
    Journal of Allergy and Clinical Immunology: Global
    10.1016/j.jacig.2024.100241

  22. Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T-cell period: Preservation of vaccine-associated antibodies between 0 and 6 months
    Reynolds, G.K., Klimevski, E., Saunders, N.R., Teenakoon, G.S., Harrison, S.J., Dowling, M., Anderson, M.A., Thursky, K., Slavin, M.A., Teh, B.W.
    British Journal of Haematology
    10.1111/bjh.19807

  23. Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes
    Haeusler, G.M., Dashti, S.G., James, F., Babl, F.E., Borland, M.L., Clark, J.E., Padhye, B., Tapp, H., Alvaro, F., Raj, T.S., Walwyn, T., Ziegler, D.S., Super, L., Hall, L., Yeoh, D.K., Butters, C., McMullan, B., Hanna, D.M.T., De Abreu Lourenco, R., Slavin, M.A., Phillips, B., Thursky, K.A.
    The Lancet Regional Health - Western Pacific
    10.1016/j.lanwpc.2024.101226

  24. Antimicrobial-resistant central line-associated bloodstream infections in adult intensive care units: findings from an Australian surveillance network, 2011–2022
    Lim, L.-L., Lim, K.W.E., Malloy, M.J., Bull, A., Brett, J., Worth, L.J.
    Infection Control and Hospital Epidemiology
    10.1017/ice.2024.132

  25. The emergence of letermovir and maribavir drug-resistant mutations: From clinical trials to real-world studies
    Zhu, V.Z., Horton, M.B., Haeusler, G.M., Yong, M.K.
    Current Opinion in Infectious Diseases
    10.1097/QCO.0000000000001065

  26. Designing a Digital Health Solution: A Platform for Automated Surveillance of Fungal Infection
    Khanina, A., Rozova, V., Elkins, S., Verspoor, K., Thursky, K.
    Studies in Health Technology and Informatics
    10.3233/SHTI231241

  27. Validation of a digital self-assessment to identify low-risk penicillin and sulfa antibiotic allergies in adults (SELF-FAST)
    Rose, M.T., Ramesh, S., Vogrin, S., Holmes, N.E., Lambros, B., Slavin, M.A., Trubiano, J.A.
    Journal of Allergy and Clinical Immunology: In Practice
    10.1016/j.jaip.2024.07.025

  28. Hospital-acquired bloodstream infections in patients with cancer: current knowledge and future directions
    MacPhail, A., Dendle, C., Slavin, M., McQuilten, Z.
    Journal of Hospital Infection
    10.1016/j.jhin.2024.03.002

  29. Protocol for a clinically annotated biorepository of samples from Australian immune-compromised patients to investigate the host-microbiome interaction
    Smibert, O.C., Trubiano, J.A., Kwong, J.C., Markey, K.A., Slavin, M.A.
    BMJ Open
    10.1136/bmjopen-2024-085504

  30. Striking the right balance: Navigating antimicrobial stewardship and antibiotic prescribing after CAR-T-cell therapy
    Reynolds, G., Smibert, O.C., Kampouri, E.
    Transplant Infectious Disease
    10.1111/tid.14395

  31. Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
    Kinsella, P.M., Moso, M.A., Morrissey, C.O., Dendle, C., Guy, S., Bond, K., Sasadeusz, J., Slavin, M.A.
    Transplant Infectious Disease
    10.1111/tid.14301

  32. Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia
    Yeoh, D.K., Haeusler, G.M., Slavin, M.A., Kotecha, R.S.
    Expert Review of Hematology
    10.1080/17474086.2024.2390639

  33. Initial empirical antibiotic therapy in kidney transplant recipients with pyelonephritis: A global survey of current practice and opinions across 19 countries on six continents
    Coussement, J., Bansal, S.B., Scemla, A., Svensson, M.H.S., Barcan, L.A., Smibert, O.C., Clemente, W.T., Lopez-Medrano, F., Hoffman, T., Maggiore, U., Catalano, C., Hilbrands, L., Manuel, O., Du Toit, T., Shern, T.K.Y., Chowdhury, N., Viklicky, O., Oberbauer, R., Markowicz, S., Kaminski, H., Lafaurie, M., Pierrotti, L.C., Cerqueira, T.L., Yahav, D., Kamar, N., Kotton, C.N.
    Transplant Infectious Disease
    10.1111/tid.14362

  34. Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes
    Wen, S.C.H., Harris, P.N.A., Forde, B., Permana, B., Chatfield, M.D., Lau, C.L., Spurling, G., Bauer, M.J., Balch, R., Chambers, H., Schlapbach, L.J., Clark, J.E., Dougherty, S., Blyth, C.C., Britton, P.N., Clifford, V., Haeusler, G.M., McMullan, B., Wadia, U., Paterson, D.L., Irwin, A.D.
    Clinical Infectious Diseases
    10.1093/cid/ciae341

  35. Intravenous amoxicillin-clavulanic acid: prescribing practices in Australian hospitals
    Chronas, A., Thursky, K., Mo, S., Hall, L., James, R., Ierano, C.
    Journal of Pharmacy Practice and Research
    10.1002/jppr.1930

  36. Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
    Alexander, M., Jachno, K., Phillips, K.-A., Seymour, J.F., Slavin, M.A., Cheung, A., Shen, V., Maarouf, D., Wolfe, R., Lingaratnam, S.
    Journal of Oncology Pharmacy Practice
    10.1177/10781552231180875

  37. Risk of Self-Reported Penicillin Allergy Despite Removal of Penicillin Allergy Label: Secondary Analysis of the PALACE Randomized Clinical Trial
    Copaescu, A.M., Vogrin, S., Douglas, A., Turner, N.A., Phillips, E.J., Holmes, N.E., Trubiano, J.A.
    JAMA Network Open
    10.1001/jamanetworkopen.2024.29621

  38. JAC Supplement: ‘Faster ID and AST Revolution: How to Improve Antibiotic Use in the Critically Ill’
    Slavin, M., Johnson, A.
    Journal of Antimicrobial Chemotherapy
    10.1093/jac/dkae285

  39. Clinicopathologic conference: Bloodstream infection in an allogeneic hematopoietic cell transplant: Thinking beyond the usual
    Yeoh, K., Lass-Flörl, C., Lamoth, F., Slavin, M.A., Williams, E., Neofytos, D.
    Transplant Infectious Disease
    10.1111/tid.14273

  40. Infections during novel myeloma therapies
    Liu, A.J., Slavin, M.A., Harrison, S.J., Teh, B.W.
    Leukemia and Lymphoma
    10.1080/10428194.2024.2428819

  41. Reassessment of the role of combination antifungal therapy in the current era
    Neoh, C.F., Slavin, M.A.
    Current Opinion in Infectious Diseases
    10.1097/QCO.0000000000001063

  42. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
    Zhao, Z., Patel, P.A., Slatnick, L., Sitthi-Amorn, A., Bielamowicz, K.J., Nunez, F.A., Walsh, A.M., Hess, J., Rossoff, J., Elgarten, C., Myers, R., Saab, R., Basbous, M., McCormick, M., Aftandilian, C., Richards, R., Nessle, C.N., Tribble, A.C., Sheth Bhutada, J.K., Coven, S.L., Runco, D., Wilkes, J., Gurunathan, A., Guinipero, T., Belsky, J.A., Lee, K., Wong, V., Malhotra, M., Armstrong, A., Jerkins, L.P., Cross, S.J., Fisher, L., Stein, M.T., Wu, N.L., Yi, T., Orgel, E., Haeusler, G.M., Wolf, J., Demedis, J.M., Miller, T.P., Esbenshade, A.J.
    Journal of Clinical Oncology
    10.1200/JCO.23.01814

  43. Cryptococcosis Associated With Biologic Therapy: A Narrative Review
    Li, X., Paccoud, O., Chan, K.-H., Yuen, K.-Y., Manchon, R., Lanternier, F., Slavin, M.A., Van De Veerdonk, F.L., Bicanic, T., Lortholary, O.
    Open Forum Infectious Diseases
    10.1093/ofid/ofae316

  44. Biomarkers to predict and diagnose pulmonary complications in children post hematopoietic stem cell transplant
    Walker, H., Haeusler, G.M., Cole, T., Neeland, M., Hanna, D., Shanthikumar, S.
    Clinical and Translational Immunology
    10.1002/cti2.70002

  45. Preneutropenic Fever in Patients With Hematological Malignancies: A Novel Target for Antimicrobial Stewardship
    Chiodo-Reidy, J., Slavin, M.A., Tio, S.Y., Ng, G., Bajel, A., Thursky, K.A., Douglas, A.P.
    Open Forum Infectious Diseases
    10.1093/ofid/ofae488

  46. Durability of penicillin allergy delabeling and post-testing penicillin utilization in adults with immune compromise
    Rose, M.T., Mitri, E.A., Vogrin, S., Holmes, N.E., Chua, K.Y.L., Slavin, M.A., Trubiano, J.A.
    Journal of Allergy and Clinical Immunology: In Practice
    10.1016/j.jaip.2024.03.047

  47. Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients
    Teh, B.W., Mikulska, M., Mueller, N.J., Slavin, M.A.
    Transplant Infectious Disease
    10.1111/tid.14154

  48. Antibacterial prophylaxis for neutropenic and high-risk hematology patients—Do the benefits outweigh the risk?
    Reynolds, G., Lindsay, J.
    Transplant Infectious Disease
    10.1111/tid.14255

  49. Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort study
    Yeoh, D.K., Blyth, C.C., Clark, J.E., Abbotsford, J., Corrente, C., Cook, S., Kotecha, R.S., Wang, S.S., Spelman, T., Slavin, M.A., Thursky, K.A., Haeusler, G.M.
    The Lancet Regional Health - Western Pacific
    10.1016/j.lanwpc.2024.101201

  50. New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections
    Neoh, C.F., Jeong, W., Kong, D.C.M., Beardsley, J., Kwok, P.C.L., Slavin, M.A., Chen, S.C.-A.
    Expert Review of Anti-Infective Therapy
    10.1080/14787210.2024.2409408

  51. Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies
    Campbell, A., Teh, B., Mulligan, S., Ross, D.M., Weinkove, R., Gilroy, N., Gangatharan, S., Prince, H.M., Szer, J., Trotman, J., Lane, S., Dickinson, M., Quach, H., Enjeti, A.K., Ku, M., Gregory, G., Hapgood, G., Ho, P.J., Cochrane, T., Cheah, C., Greenwood, M., Latimer, M., Berkahn, L., Wight, J., Armytage, T., Diamond, P., Tam, C.S., Hamad, N.
    Internal Medicine Journal
    10.1111/imj.16303

  52. Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate
    Maertens, J., Slavin, M., Hoenigl, M., Thompson III, G.R., Richardson, M., Lass-Flörl, C.
    Journal of Antimicrobial Chemotherapy
    10.1093/jac/dkae158

  53. Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions
    Tio, S.Y., Chen, S.C.A., Heath, C.H., Pradhan, A., Morris, A.J., Korman, T.M., Morrissey, C.O., Halliday, C.L., Kidd, S., Spelman, T., Brell, N., McMullan, B., Clark, J.E., Mitsakos, K., Hardiman, R.P., Williams, P.C.M., Campbell, A.J., Beardsley, J., Van Hal, S., Yong, M.K., Worth, L.J., Slavin, M.A.
    Open Forum Infectious Diseases
    10.1093/ofid/ofae594

  54. Extended duration of letermovir prophylaxis: how long is long enough?
    Douglas, A.P., Slavin, M.A.
    The Lancet Haematology
    10.1016/S2352-3026(23)00368-X

  55. Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration
    Weerdenburg, H., Walker, H., Curtis, N., Duffull, S., Haeusler, G., Cole, T., Gwee, A.
    Journal of Antimicrobial Chemotherapy
    10.1093/jac/dkae099

  56. Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease
    Rees, M.J., Rivalland, A., Tan, S., Xie, M., Yong, M.K., Ritchie, D.
    Annals of Hematology
    10.1007/s00277-023-05526-6

  57. Invasive fungal disease in children with solid tumors: An Australian multicenter 10-year review
    Jain, N., Ryan, A.L., Haeusler, G.M., McMullan, B.J., Moore, A.S., Bartlett, A.W., Blyth, C.C., Kotecha, R.S., Yeoh, D.K., Clark, J.E.
    Pediatric Blood and Cancer
    10.1002/pbc.31031

  58. The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions
    James, F., Goh, M.S., Vogrin, S., Ng, I., Douglas, A.P., Holmes, N.E., Chua, K.Y., De Luca, J., Sharma, P., Zubrinich, C., Aung, A.K., Gin, D., Lambros, B., Baker, C., Foley, P., Chong, A.H., Thien, F., Fok, J.S., Su, J., Scardamaglia, L., Awad, A., Tong, S., Johnson, D., Godsell, J., Arasu, A., Barnes, S., Ojaimi, S., Mar, A., Yun, J., Ange, N., Tong, W.W.Y., Carr, A., Loprete, J., Katelaris, C.H., Slape, D., Keat, K., West, T.A., Lee, M., Smith, W., Hissaria, P., Sidhu, S., Janson, S., Venkatesan, S., Davies, J., Lane, M.J., Redmond, A.M., Robertson, I., Legg, A., Fernando, S., Boyle, T., Li, J., Phillips, E.J., Cleland, H., Kern, J.S., Trubiano, J.A.
    World Allergy Organization Journal
    10.1016/j.waojou.2024.100936

  59. Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges
    Giannella, M., Lanternier, F., Dellière, S., Groll, A.H., Mueller, N.J., Alastruey-Izquierdo, A., Slavin, M.A.
    Clinical Microbiology and Infection
    10.1016/j.cmi.2024.08.006

  60. Neutropenic Sepsis in the Intensive Care Unit: Differences in Clinical Profile and Outcomes According to the Cause of Neutropenia
    MacPhail, A., Dendle, C., Slavin, M., Weinkove, R., Bailey, M., Pilcher, D., McQuilten, Z.
    Open Forum Infectious Diseases
    10.1093/ofid/ofae289